Ranbaxy shares dip post US drug recall
The shares of Ranbaxy Laboratories Ltd fell as much as 3.8 per cent on Monday after it recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States.
Mumbai: The shares of Ranbaxy Laboratories Ltd fell as much as 3.8 per cent on Monday after it recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States. A doseage mix-up was also detected.
Ranbaxy confirmed the recall of select batches of the drug, a generic version of Pfizer Inc's Lipitor, but mentioned that the company had not received any product complaints.
Shares in Ranbaxy, India's biggest drugmaker by revenue and majority owned by Japan's Daiichi Sankyo Co Ltd were down 2.9 percent, underperforming a 0.3 percent fall in the Nifty.
Next Story
